The news out of Switzerland this month is that Applied Pharma Research (APR) is going to be marketing a new migraine drug in Canada and the USA. Well, new in a sense.
You may have heard of the NSAID, Cataflam. Cataflam is commonly used for arthritis. Its medicinal ingredient is diclofenac potassium.
The migraine drug will contain the same ingredient, but will be specially formulated to be fast-acting. This is important, of course, for a migraineur. Getting the drug into your system as soon as possible seems to increase the chances of success. APR claims that your blood steam can have peak levels of the drug within 12-15 minutes. If NSAIDs help you, this may be a new option that provides quick relief.
Read more in APR’s press release.
Popularity: 1% [?]
Loading ...
